scPharmaceuticals SCPH 深 滬
等待開盤 12-25 09:30:00 美东时间
5.67
0.000
0.00%
華盛通- 最 高--
- 今 開--
- 成交量 0股
- 最 低 --
- 昨 收 5.67
- 總市值 3.04亿
- 52周最高 6.2799
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 1.94
- 委 比 0.00%
- 總股本 5367.88万
- 歷史最高 18.17
- 量 比 0
- 振 幅 0.00%
- 歷史最低 1.94
- 每 手 1
- 風險率 1.08%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多MannKind Shares FUROSCIX® Business Updates
FDA approves FUROSCIX for pediatric patients weighing 43kg or above, expanding its use beyond adults with chronic heart failure and kidney disease. Additionally, five new patents for the FUROSCIX ReadyFlow Autoinjector provide extended intellectual property protection through 2040, reinforcing MannKind's position. The autoinjector, currently under FDA review, aims to deliver diuretic doses in seconds, potentially reducing hospital visits and impr...
12-23 13:05
MannKind Announces U.S. FDA Accepts for Review its Supplemental New Drug Application (sNDA) of FUROSCIX ReadyFlow™ Autoinjector for the Treatment of Edema in Adults with Chronic Heart Failure or Chronic Kidney Disease
MannKind Corporation announced the FDA acceptance of the sNDA for FUROSCIX ReadyFlow Autoinjector, designed to deliver a subcutaneous furosemide dose in under 10 seconds for adult patients with chronic heart failure or kidney disease. If approved, it would offer a faster, more convenient alternative to the current 5-hour on-body infusor, potentially reducing hospital admissions and healthcare costs. The PDUFA target action date is July 26, 2026.
12-01 13:05
MannKind's Afrezza under supplemental FDA review
MannKind Corporation (MNKD) announced that the U.S. FDA has accepted the supplemental marketing application seeking approval for Afrezza (insulin human) inhalation powder in children and adolescents l...
10-13 21:43
scPharmaceuticals Completes Merger and Delists from Nasdaq
The latest update is out from scPharmaceuticals ( ($SCPH) ). On October 7, 2025...
10-07 21:44
scPharmaceuticals Issues Promissory Note to MannKind
The latest update is out from scPharmaceuticals ( ($SCPH) ). On September 23, 2...
09-25 16:25
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BRY, SCPH, WKHS on Behalf of Shareholders
NEW YORK, Sept. 22, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/o...
09-22 20:46
华兴资本医疗与生命科技行业周报【Vol.382】
来源：华兴资本 “华兴资本医疗与生命科技行业周报”定期发布，专注从资本角度解读一周数据，并提供最新行业观察。 医疗与生命科技是华兴资本多年来关注并深耕的领域，目...
09-01 08:30
美股大行评级 | 潜在涨幅163.16%！HIVE Digital Technologies获Roth Capital升目标价至7.5美元，维持"买入"评级
今日重点评级关注：Roth Capital：维持HIVE Digital Technologies"买入"评级，目标价从6美元升至7.5美元；Craig-Hallum：维持Ranpak Hldgs"买入"评级，目标价从8美元升至10美元
08-27 08:32
Craig-Hallum Downgrades scPharmaceuticals to Hold, Announces $6 Price Target
Craig-Hallum analyst Chase Knickerbocker downgrades scPharmaceuticals (NASDAQ:SCPH) from Buy to Hold and announces $6 price target.
08-27 02:01
Maxim Group Downgrades scPharmaceuticals to Hold
Maxim Group analyst Naz Rahman downgrades scPharmaceuticals (NASDAQ:SCPH) from Buy to Hold.
08-26 02:57
